Literature DB >> 22959007

Significance of genetic variation of PRRSV ORF5 in virus neutralization and molecular determinants corresponding to cross neutralization among PRRS viruses.

Won-Il Kim1, Jae-Jo Kim, Sang-Ho Cha, Wai-Hong Wu, Vickie Cooper, Rich Evans, En-Jin Choi, Kyoung-Jin Yoon.   

Abstract

A high rate of genetic and antigenic variability among porcine reproductive and respiratory syndrome viruses (PRRSVs) hampers effective prevention and control of the disease caused by PRRSV. The major envelope protein (GP5) encoded by the ORF5 of PRRSV has a critical role in inducing virus neutralizing (VN) antibody and cross protection among different strains of PRRSV. This study was conducted to identify sequence elements related to cross neutralization by comparing the ORF5 sequences of 69 field isolates in conjunction with their susceptibility to VN antibody raised against the VR2332 strain in vitro and in vivo. Five common variable sites (amino acid position 32-34, 38-39, 57-59, 137 and 151) were identified between susceptible and resistant viral isolates. Mutants whose ORF5 amino acid sequences were substituted with the sequences corresponding to the 5 identified common variable sites individually or concurrently were generated from a VR2332-backboned infectious clone by site mutagenesis. The change in the susceptibility of the mutants to VN antibodies specific for VR2332 or a heterologous PRRSV was assessed to determine the association of those 5 identified sites with cross neutralization. Among the five sites, the changes of amino acid sequences at three sites (32-34, 38-39, and 57-59) located in the N-terminal ectodomain of ORF5 significantly influenced the susceptibility of the mutant viruses to VN antibody, suggesting that sequence homology at these sites can be utilized as genetic markers to predict the degree of cross neutralization among different PRRSVs.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22959007     DOI: 10.1016/j.vetmic.2012.08.005

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  19 in total

1.  Development of a chimeric strain of porcine reproductive and respiratory syndrome virus with an infectious clone and a Korean dominant field strain.

Authors:  Jung-Ah Lee; Nak-Hyung Lee; Sang-Won Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Joong-Bok Lee
Journal:  J Microbiol       Date:  2014-03-29       Impact factor: 3.422

2.  Nsp2 and GP5-M of Porcine Reproductive and Respiratory Syndrome Virus Contribute to Targets for Neutralizing Antibodies.

Authors:  Jia Su; Lei Zhou; Bicheng He; Xinhui Zhang; Xinna Ge; Jun Han; Xin Guo; Hanchun Yang
Journal:  Virol Sin       Date:  2019-07-25       Impact factor: 4.327

3.  Efficacy of a type 2 PRRSV modified live vaccine (PrimePac™ PRRS) against a Thai HP-PRRSV challenge.

Authors:  Chaitawat Sirisereewan; Yonlayong Woonwong; Jirapat Arunorat; Roongtham Kedkovid; Teerawut Nedumpun; Sawang Kesdangsakonwut; Sanipa Suradhat; Roongroje Thanawongnuwech; Komkrich Teankum
Journal:  Trop Anim Health Prod       Date:  2018-04-26       Impact factor: 1.559

4.  Evaluation of the Cross-Protective Efficacy of a Chimeric Porcine Reproductive and Respiratory Syndrome Virus Constructed Based on Two Field Strains.

Authors:  Nadeem Shabir; Amina Khatun; Salik Nazki; Bumseok Kim; Eun-Jin Choi; Dong Sun; Kyoung-Jin Yoon; Won-Il Kim
Journal:  Viruses       Date:  2016-08-22       Impact factor: 5.048

5.  Establishment of Systems to Enable Isolation of Porcine Monoclonal Antibodies Broadly Neutralizing the Porcine Reproductive and Respiratory Syndrome Virus.

Authors:  David Goldeck; Dana M Perry; Jack W P Hayes; Luke P M Johnson; Jordan E Young; Parimal Roychoudhury; Elle L McLuskey; Katy Moffat; Arjen Q Bakker; Mark J Kwakkenbos; Jean-Pierre Frossard; Raymond R R Rowland; Michael P Murtaugh; Simon P Graham
Journal:  Front Immunol       Date:  2019-03-27       Impact factor: 7.561

6.  Development of a bead-based assay for detection and differentiation of field strains and four vaccine strains of type 2 porcine reproductive and respiratory syndrome virus (PRRSV-2) in the USA.

Authors:  Yin Wang; Wannarat Yim-Im; Elizabeth Porter; Nanyan Lu; Joe Anderson; Lance Noll; Ying Fang; Jianqiang Zhang; Jianfa Bai
Journal:  Transbound Emerg Dis       Date:  2020-09-08       Impact factor: 5.005

7.  Phylogenetic Structure and Sequential Dominance of Sub-Lineages of PRRSV Type-2 Lineage 1 in the United States.

Authors:  Igor A D Paploski; Nakarin Pamornchainavakul; Dennis N Makau; Albert Rovira; Cesar A Corzo; Declan C Schroeder; Maxim C-J Cheeran; Andrea Doeschl-Wilson; Rowland R Kao; Samantha Lycett; Kimberly VanderWaal
Journal:  Vaccines (Basel)       Date:  2021-06-05

8.  Isolation of Porcine Reproductive and Respiratory Syndrome Virus GP5-Specific, Neutralizing Monoclonal Antibodies From Hyperimmune Sows.

Authors:  Jordan E Young; Cheryl M T Dvorak; Simon P Graham; Michael P Murtaugh
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

Review 9.  Improved Vaccine against PRRSV: Current Progress and Future Perspective.

Authors:  Yuchen Nan; Chunyan Wu; Guoqian Gu; Weiyao Sun; Yan-Jin Zhang; En-Min Zhou
Journal:  Front Microbiol       Date:  2017-08-28       Impact factor: 5.640

Review 10.  Recent advances in veterinary applications of structural vaccinology.

Authors:  Bryan Charleston; Simon P Graham
Journal:  Curr Opin Virol       Date:  2018-03-16       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.